Ginekol Pol
-
Review of literature on novel therapy for severe sepsis within recombinant human protein C (rhAPC). ⋯ Sufficient data are available to approve rhAPC for treatment of patients with severe sepsis. Both anticoagulant and antiinflammatory properties of rhAPC, as well as profibrinolytic activity, are the rationale for the use of rhAPC.